Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Onconova Therapeutics Inc. (ONTX)

0.8312   0.115 (16.12%) 01-17 17:16
Open: 0.708 Pre. Close: 0.7158
High: 0.8669 Low: 0.7
Volume: 69,815,483 Market Cap: 172M
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. The company is headquartered in Newtown, Pennsylvania and currently employs 25 full-time employees. The firm operates through the identification and development of oncology therapeutics segment. The company is focused on discovering and developing small molecule drug candidates to treat cancer. The firm has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. The company has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The firm's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.871 - 0.874 0.874 - 0.877
Low: 0.693 - 0.696 0.696 - 0.699
Close: 0.824 - 0.83 0.83 - 0.835

Technical analysis

as of: 2021-01-15 4:43:54 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 1.11     One year: 1.30
Support: Support1: 0.55    Support2: 0.30
Resistance: Resistance1: 0.95    Resistance2: 1.11
Pivot: 0.61
Moving Average: MA(5): 0.72     MA(20): 0.56
MA(100): 0.33     MA(250): 0.46
MACD: MACD(12,26): 0.11     Signal(9): 0.09
Stochastic oscillator: %K(14,3): 62.81     %D(3): 58.30
RSI: RSI(14): 71.05
52-week: High: 1.56  Low: 0.19  Change(%): 102.7
Average Vol(K): 3-Month: 2490053  10-Days: 6387442

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ONTX has closed below upper band by 7.9%. Bollinger Bands are 75.3% wider than normal. The large width of the bands suggest high volatility as compared to ONTX's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.

Headline News

Thu, 14 Jan 2021
Onconova Therapeutics, Inc. to Present at NobleCon17 Virtual Event - Yahoo Finance

Thu, 14 Jan 2021
Onconova Therapeutics (NASDAQ:ONTX) Upgraded to "Hold" by Zacks Investment Research - MarketBeat

Mon, 11 Jan 2021
Prelude, Onconova plan multimillion-dollar stock sales - Philadelphia Business Journal

Thu, 07 Jan 2021
Onconova Therapeutics announces $8.7M registered direct offering - Seeking Alpha

Wed, 06 Jan 2021
Onconova Therapeutics (ONTX) Hits Multi-Month High on value Buying - Own Snap

Wed, 30 Dec 2020
3 Penny Stocks To Buy On Robinhood Up Over 80% In Q4 2020 - Penny Stocks

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 185
Shares Float (M) 184
% Held by Insiders 0.56
% Held by Institutions 11.21
Shares Short (K) 9,780
Shares Short P. Month (K) 11,430

Stock Financials

EPS -0.178
EPS Est This Year -2.860
EPS Est Next Year -2.100
Book Value (p.s.) 0.070
Profit Margin
Operating Margin -11923.04
Return on Assets (ttm) -97.4
Return on Equity (ttm) -792.8
Qtrly Rev. Growth 4.8
Gross Profit (p.s.) 0.012
Sales Per Share 0.001
EBITDA (p.s.) -0.131
Qtrly Earnings Growth
Operating Cash Flow (M) -23
Levered Free Cash Flow (M) -14

Stock Valuations

PE Ratio -4.67
PEG Ratio
Price to Book value 11.87
Price to Sales 753.58
Price to Cash Flow -6.69

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.